Executive Team
Anh-Hoa Nguyen, PhD, MBA
Chief Executive Officer
Dr. Anh-Hoa Nguyen has almost two decades of working experience in academic centers, biotechnology industry, and clinical research organizations. Her research interests include study design, model selection, predictive modeling, and machine learning. She has extensive experience working with cross functional teams to collaborate on study design, protocol development, and statistical analysis plans. She has hand-on experience with the new drug application process with the FDA in the United States and the EMA in Europe. Dr. Anh-Hoa Nguyen has worked on clinical trials and large-scale health studies in infectious disease, oncology, cardiovascular disease, endocrinology and metabolism. She has also provided technical and operational training courses. She received her Ph.D. in Biostatistics from the Boston University Graduate School of Arts and Sciences and School of Public Health and her MBA from Golden Gate University.
Kim-Son Nguyen, MD, MPA
Chief Medical Officer
Dr. Kim-Son Nguyen is a medical oncologist at Palo Alto Medical Foundation, Sutter Health, California. His research interests include targeted therapy for non-small cell lung cancer, molecular epidemiology of lung cancer, lung cancer screen in minority community, and cancer care delivery. He has been principal investigator and co-investigator of many cancer trials. He was the former director of the Vietnam Program of the American Society of Clinical Oncology. Dr. Nguyen received his BA from Harvard College, MPA from the Harvard Kennedy School of Government, and MD from Harvard Medical School. He was a graduate of the Global Health Effectiveness Program at the Harvard School of Public Health. Dr. Nguyen did his training in internal medicine at Beth Israel Deaconess Medical Center, Harvard Medical School and his fellowship in hematology-oncology at Stanford University School of Medicine.
Bao Nguyen
Chief Technology Officer
Bao Nguyen has over 25 years of experience in networking, systems architecture design, and development in health care informatics. He co-founded Berkeley Information and Technologies as a contract research organization providing large-scale public health and clinical trial data management for the University of California, San Francisco, University of California, Berkeley, Kaiser Permanente, and biotechnology companies.
He served as Senior Director of Information Technology and Clinical Data Management at OneWorld Health, the first non-profit pharmaceutical company in the world, and more recently at Medicines360. His
involvements with major non-profit pharmaceuticals led him back to Vietnam where he began a number of collaborative efforts to improve healthcare research and urban infrastructures.
Gene Yamamoto, JD, MBA
General Counsel
Mr. Yamamoto is the founder of the Law Offices of Eugene K. Yamamoto. He was previously a partner at Landels, Ripley and Diamond, a law firm in San Francisco, California, and later a partner at Crosby, Heafey, Roach and May in Oakland, California. He also served as an adjunct professor at Golden Gate University School of Law. During his career he has represented many Fortune 500 corporations and start-up companies. Mr. Yamamoto has served on many boards of directors of private companies as well as charitable organizations. He received his BA and MBA from Loyola Marymount University and his JD from Hastings College of the Law.
Board of Advisors
Long Ngo, PhD
Dr. Ngo is a faculty member at Harvard University. He has a joint appointment at both Harvard Medical School and the Harvard T.H. Chan School of Public Health. Dr. Ngo is the director of the biostatistics group in the Division of General Medicine at Beth Israel Deaconess Medical Center. He is the principal investigator and co-investigator of many National Institute of Health research grants on aging, delirium, cancer, cardiology, radiology, and biomarkers. Dr. Ngo’s research interest is on statistical methodology of longitudinal data analysis, model selection, and machine learning methods. Dr. Ngo has trained many students, residents, fellows, junior investigators, and has published more than 200 papers in scientific journals. He is the past chairperson of the 9-member National Committee on Statistics and Disability for the American Statistical Association and has been a member of editorial boards for several scientific journals. He is also a scientific reviewer for more than 10 journals. Dr. Ngo received his Ph.D. in Biostatistics at the University of California at Berkeley and completed his fellowship in the Department of Biostatistics at Harvard University.
Jiming Jiang, PhD
Dr. Jiang is a Professor of Statistics at the University of California, Davis. His research interests include mixed effects models, model selection, small area estimation, longitudinal data analysis, precision medicine, Big Data intelligence, statistical genetics, bioinformatics, pharmacokinetics, and asymptotic theory. He has published over 100 research papers in top statistical journals and is the author of five books and monographs. He has served on the editorial boards of several major statistical journals including The Annals of Statistics and Journal of the American Statistical Association. He is a Fellow of the American Association for the Advancement of Science, a Fellow of the American Statistical Association, a Fellow of the Institute of Mathematical Statistics, and an Elected Member of the International Statistical Institute. He has received numerous awards from professional societies, the National Science Foundation, and National Institutes of Health. He received his Ph.D. in Statistics from the University of California, Berkeley.
Ulrike Knappes, MD, PhD, MPH
Dr. Ulrike Knappes is the Assistant Director of Cytogenetics, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School. She is responsible for accurate, reliable, and timely cytogenetic testing. She teaches fellows and residents in the Department of Pathology. Prior to coming to Harvard, she was the Medical Director of Genomic Pathology and Associate Directors of Cytogenetics in the Department of Pathology and Laboratory Medicine at Tufts Medical Center and Assistant Professor of Pathology at Tufts University School of Medicine. She was previously the Director of the Sequencing Laboratory in the Genomic Sciences and Precision Medicine Center at Children's Hospital of Wisconsin and Assistant Professor of Medical College of Wisconsin. Prior to these academic appointments, Dr. Knappes was an Assistant Laboratory Director at Myriad Genetic Laboratories and Associated Medical Director at Interleukin Genetics. She received her MD/PhD from Julius-Maximilians-Universitat, Germany, and her MPH from the Harvard T. H. Chan School of Public Health.